(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Despite considerable effort in primary prevention, coronary heart disease continues to be the leading cause of death in the industrialized nations. The patient who survives his first myocardial infarction carries approximately a tenfold risk of recurrence and sudden death when compared to the normal population. The concept of secondary prevention, therefore, has emerged as an active strategy aimed at the reduction of fatal and non-fatal recurrences of myocardial infarction. Apart from risk factors of relevance in primary prevention, secondary prevention is dependent on the extent of the disease itself; in other words the number of vessels involved, the extent of myocar dial damage and the degree of electrical instability. Nonmedical aspects such as the level of education, the degree of social support and the attitude towards stress also appear to influence the prognosis. The aim of this volume is to bring together all those factors relevant to achieving the maximal life span in patients afflicted with a disease that by its very nature is a lifelong process. However, as the late Paul Dudley White stated appropriately more than 40 years ago, it is not sufficient merely to add years to a life, one should also add life to the years. This concept truly is the nucleus of secondary prevention, sine only a life worth living generates the motivitation needed to take all the steps necessary in secondary pre vention. The authors and the editor are most grateful to Pharma Schwarz Inc.
Contents:
One: The Role of Risk Factors in Secondary Prevention.- 1. Cessation of Smoking.- 2. The Importance of the Cessation of Cigarette Smoking in the Tertiary Prevention of Coronary Heart Disease.- 3. Control of Hypertension.- 4. Lipid Lowering Regimens in Secondary Prevention of Coronary Heart Disease.- Two: The Role of Social Class in Secondary Prevention.- 5. Mortality after Myocardial Infarction. Role of Social and Behavioral Factors.- 6. The Impact of Social Level on Prognosis after Myocardial Infarction.- 7. Social Class and Prognosis in Coronary Heart Disease.- 8. Short and Long-term Prognosis After First Myocardial Infarction. Influences of Social Class.- Three: The Role of Medication in Secondary Prevention.- 9. Beta-blocking Agents in Secondary Prevention.- 10. Beta-Blocking Agents in Secondary Prevention After Acute Myocardial Infarction with Special Reference to the European Infarct Study (EIS).- 11. Platelet Aggregation Inhibitors.- 12. Platelet Inhibitors or Anticoagulants for Prevention of Aorto-coronary Bypass Graft Occlusion.- 13. Cardiovascular Protection by Calcium Antagonists.- 14. The Influence of Nitrates on Prognosis in Patients with Coronary Heart Disease.- 15. Metabolic Aspects of Preventive Drug Administration.- Four: The Role of Physical Exercise in Secondary Prevention.- 16. The Role of Physical Exercise in Secondary Prevention. Evidence to Date.- 17. The Behavior of the Ejection Fraction at Rest and Exercise in Myocardial Infarction Before and After a 4-week Training Period. Comparison to a Control Group.- 18. Adaptations to Prolonged Intense Exercise Training in Ischemic Heart Disease.- 19. Physical Activity and Sudden Death.- 20. Physical Exercise and Sympathetic Drive.- 21. Physical Exercise in Comprehensive Care.- 22. Exercise Capacity and Regional Myocardial Perfusion Distribution in Ischemic Heart Disease with and without Collateral Vessels.- Five: The Role of Psychosocial Factors in Secondary Prevention.- 23. Alteration of Type A Behavior and its Effect Upon the Cardiac Recurrence Rate in Post-myocardial Infarction Patients.- 24. A 5-year Controlled Clinical Trial on Psychological Well-being.- 25. Psychosomatic Aspects in Secondary Prevention.- 26. Social Isolation and Attitudes Towards Stress. A Behavioral Trap for Patients After Myocardial Infarction.- Six: The Role of Reperfusion in Secondary Prevention.- 27. Effect of Percutaneous Transluminal Coronary Angioplasty.- 28. Single Vessel Stenosis After Acute Myocardial Infarction: Which Patients Should Undergo Percutaneous Transluminal Coronary Angioplasty?.- 29. The Role of Coronary Bypass Surgery in Rehabilitation.- 30. Social Fate after Aorto-coronary Bypass Surgery.- 31. Clinical and Occupational Status of Patients with Coronary Artery Disease After Surgical Reperfusion.- 32. Which Factors do Influence the Rate of Employment After Surgical and Medical Treatment in Patients with Coronary Heart Disease?.- 33. Late Results of Reperfusion with Intracoronary Streptokinase.- 34. Percutaneous Transluminal Coronary Angioplasty After Thrombolysis to Prevent Reinfarction.
PRODUCT DETAILS
Publisher: Springer
Publication date: October, 2011
Pages: 420
Weight: 557g
Availability: Available
Subcategories: Cardiovascular Medicine
From the same series
Jean-Claude Tardif
Xander H T Wehrens
Johan H. C. Reiber
Raimund Erbel
M.P. Sambhi
Pedro Brugada
W. Bleifeld
Naranjan S. Dhalla
Bohuslav Ostadal
Ralph Shabetai
Jason X.-J. Yuan
Hein J.J. Wellens
R. C. Becker
Franz H. Messerli
C.H. Peels
Stephen M. Factor
Hiroyuki Suga
Hugo Ector
Brian E. Jaski
Richard A. Walsh
Seymour Glagov
Michiel J. Janse
Lloyd W. Klein
Thomas H Marwick
Ernst E. van der Wall
P.J. Walter
Ernst E. van der Wall
Ernst E. van der Wall
A-M. Salmasi
Michel Emile Safar
A-M. Salmasi
Ernst E. van der Wall
Andrea Natale
Albert de Roos
C.A. Nienaber
Guillem Pons-Llado
Vinzenz Hombach
R. Vos
J. Candell-Riera
R.W. Stout
Peter Hanrath
Johan H. C. Reiber
P.A.F.M. Doevendans
Jack Rychik
P.A.F.M. Doevendans
P.E. Vardas
Makoto Nagano
George D. Dangas
Myrvin H. Ellestad
C.J. Preusse
Thomas H Marwick
Thomas H Marwick
Ernst E. van der Wall
G.T. Meester
A.G. Herman
J.C. Tardif
P.J. Walter
Johan H. C. Reiber
Ernst E. van der Wall
Lloyd W. Klein
Akira Matsumori
Robert L. Wilensky
Bernard Swynghedauw
Juan Carlos Kaski
Franz H. Messerli
John F. Keaney Jr.
Keith L. March
Naranjan S. Dhalla
Zainul Abedin
Juan Carlos Kaski
Eric J Topol
A.V. Bruschke
Richard C. Becker
J. Candell-Riera
Ghassan Bkaily
Lionel H. Opie
Bernard Swynghedauw
Geoffrey Burnstock
P. Cummins
Nicholas Sperelakis
Mina Rajskina
A.A. Knowlton
Johan H. C. Reiber
Irene D. Turpie
J. A. E. Spaan
Ernst E. van der Wall
Masatsugu Hori
Bing Liem Liong
R. Fagard
M. Iwase
R. Stroobandt
A.V. Bruschke
David M. Mirvis
Franz H. Messerli
G. Assmann
Melvin Scheinman
J. Morganroth
J.W. de Jong
M.B. Rosenbaum
C. Tissa Kappagoda
H.V. Villareal
J. Morganroth
Ernst E. van der Wall
Naranjan S. Dhalla
H. Mitchell Perry Jr.
M.P. Spencer
Henk Keurs
C.T. Lancée
J.R. Roelandt
G.S. Wagner
H. Kesteloot
A.C. Arntzenius
Johan H. C. Reiber
A. Maseri
Michel Emile Safar
M.P. Spencer
W. Bleifeld
Henk Keurs
Willem H. Birkenhager
Antonio Bayes de Luna
J.R. Roelandt
Naranjan S. Dhalla
H. Rijsterborgh
Marianne J. Legato
Naranjan S. Dhalla
S. Chien
Rafael Beyar
H.E. Van Dam
M.P. Spencer
J.R. Roelandt
Hilbert J.Th. Thalen
C. Marchesi
J.P.M Hamer
Rafael Beyar
L.N. Bouman
A. Alboni
Douglas P. Zipes
Nicholas Sperelakis
Borys Surawicz
Antonio Bayes de Luna
Johan H. C. Reiber
Hein J.J. Wellens
J.V. Chapman
E. Aliot
Vinzenz Hombach
Michael R. Rosen
William H. Gaasch
Pawan K. Singal
Robert Plonsey
H.L. Stone
J. Soler-Soler
Ernst E. van der Wall
Michel Emile Safar
J. Morganroth
Hein J.J. Wellens
J.R. Roelandt
Vinzenz Hombach
Richard S. Meltzer
Marvin A. Konstam
Naranjan S. Dhalla
Naranjan S. Dhalla
S.N. Willich
Johan H. C. Reiber
C.A. Nienaber
Ernst E. van der Wall
Robert J. Siegel
Markus Schwaiger
Andrew Wechsler
Elliot Rapaport
Naranjan S. Dhalla
John E. Tooke
Derek Yellon
Henk Keurs
Steve M. Teague
J.W. de Jong
Naranjan S. Dhalla
Nicholas Sperelakis
P.H. Heintzen
J. Morganroth
John B. Lombardini
Adam Schneeweiss
J.R. Roelandt
Naranjan S. Dhalla
Naranjan S. Dhalla
J.C. Chatham
Pim J. de Feyter
David W. Holt
Catherine A. Neill
J. Roelandt
A.P. Shepherd
Gastone Leonetti
Nico H.J. Pijls
K. Robinson
P.A.F.M. Doevendans
Douglas P. Zipes
Jose Marin-Garcia
Jonathan S. Steinberg
Francisco Villarreal
Dick Macdonald
Ragavendra R. Baliga
Dick Macdonald